Home cholesterol
 

Keywords :   


Tag: cholesterol

UPDATE 1-Regeneron, Sanofi drug slashes cholesterol in late-stage trial

2013-10-16 10:56:26| Biotech - Topix.net

A new type of cholesterol drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA, when used by itself, cut levels of "bad" LDL cholesterol almost in half in the first of a dozen late-stage trials of the injectable medicine.

Tags: update trial drug cholesterol

 

Tests of new cholesterol drug ALN-PCS suggest it can cut levels by more than half

2013-10-03 04:12:20| Biotech - Topix.net

Scientists claim ALN-PCS works by switching off a gene that reduces the body's ability to clear harmful blood fats naturally.

Tags: more than half levels

 
 

FDA Approves Mercks LIPTRUZET (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol

2013-05-03 21:06:15| Merck.com - Research & Development News

Dateline City:  WHITEHOUSE STATION, N.J. LIPTRUZET Approved for Patients with Primary or Mixed Hyperlipidemia, as an Adjunct to Diet When Diet Alone Is Not Enough Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved LIPTRUZET(ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. Language:  English Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: product lower cholesterol fda

 

US scientists develop tomatoes that mimic good cholesterol

2013-03-21 01:00:00| Food Processing Technology

Researchers at the University of California, Los Angeles (UCLA) have developed genetically engineered tomatoes that could produce a peptide that acts like the main protein in good cholesterol when consumed.

Tags: good develop scientists cholesterol

 

Merck settles investor suits on cholesterol drugs

2013-02-14 18:15:13| Biotech - Topix.net

Merck & Co. has agreed to pay $688 million to settle two lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales.

Tags: drugs investor suits cholesterol

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »